The effect of chronic lithium treatment on serotonergic neurotransmission
Description
The effect of chronic lithium treatment on [3H]5-HT release and its regulation by presynaptic mechanisms was studied in [3H]5-HT preloaded superfused rat cortical, hippocampal and hypothalamic slices. The data indicate that long-term but not acute lithium administration (1) increases Ca2+-dependent. 65 mM K+-evoked [3H]5-HT efflux in the three brain areas examined, (2) induces a decrease in spontaneous [3H]5-HT efflux in the cortex and hypothalamus and with an increase in basal hippocampal 5-HT efflux, (3) depresses the maximal functional capacity of presynaptic serotonin autoreceptors, and (4) profoundly inhibits protein skinase C-mediated potentiation of both K+-evoked and basal [3H]5-HT efflux. The mechanism underlying lithium's effect on protein kinase C-related function was further investigated. The results indicate that PMA (phorbol 12-myristate, 13-acetate) increased protein kinase C translocation from cytosol to membrane-bound fractions. Following the activation of protein kinase C by PMA, the levels of immunoprecipitated MAPs, TAU and α-tubulin, were found to be increased
Availability note (English)
University Microfilms, PO Box 1764, Ann Arbor, MI 48106, Order No.89-03,983.Additional details
Publishing Information
- Publisher
- Medical College of Pennsylvania.
- Imprint Place
- Philadelphia, PA (USA)
- Imprint Pagination
- 185 p.
INIS
- Country of Publication
- United States
- Country of Input or Organization
- United States
- INIS RN
- 21053285
- Subject category
- S61: RADIATION PROTECTION AND DOSIMETRY; S60: APPLIED LIFE SCIENCES;
- Resource subtype / Literary indicator
- Thesis, Non-conventional Literature
- Descriptors DEI
- BIOLOGICAL EFFECTS; BRAIN; CALCIUM COMPOUNDS; CHRONIC EXPOSURE; ENZYME ACTIVITY; INHIBITION; LITHIUM; MEMBRANE TRANSPORT; PHORBOL ESTERS; PHOSPHOTRANSFERASES; PHYSIOLOGY; SEROTONIN; TRACER TECHNIQUES; TRITIUM COMPOUNDS
- Descriptors DEC
- ALKALI METALS; ALKALINE EARTH METAL COMPOUNDS; AMINES; AUTONOMIC NERVOUS SYSTEM AGENT; AZOLES; BODY; CENTRAL NERVOUS SYSTEM; DRUGS; ELEMENTS; ENZYMES; ESTERS; HETEROCYCLIC COMPOUNDS; HYDROGEN COMPOUNDS; HYDROXY COMPOUNDS; INDOLES; ISOTOPE APPLICATIONS; METALS; NERVOUS SYSTEM; NEUROREGULATORS; ORGANIC COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; ORGANS; PHOSPHORUS-GROUP TRANSFERASES; PYRROLES; RADIOPROTECTIVE SUBSTANCES; RESPONSE MODIFYING FACTORS; SYMPATHOMIMETICS; TRANSFERASES; TRYPTAMINES